TY - CHAP M1 - Book, Section TI - Botulinum Toxins for the Treatment of Headaches A1 - Malik, Atif B. A1 - Sohail, Maaz A1 - Bajwa, Zahid H. A2 - Bajwa, Zahid H. A2 - Wootton, R. Joshua A2 - Warfield, Carol A. PY - 2016 T2 - Principles and Practice of Pain Medicine, 3e AB - Since the 1980s, botulinum toxins (BTXs) have been used for many putative conditions that cause pain. The U.S. Food and Drug Administration (FDA) has approved BTX type A as a prophylactic treatment for headaches due to chronic migraines and approved both BTX type A and B for other medical conditions associated with pain and discomfort. Although BTX is currently not approved for any other headache disorders, it continues to be used successfully by a range of specialists to address pain control. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1131932922 ER -